Pharmaceutical manufacturing

August 08, 2018 - 12:39 am
BEIJING (AP) — China's National Health Commission says investigators have begun recalling defective vaccines produced by a Chinese drugmaker from domestic and overseas markets. Investigators say they found Changchun Changsheng Life Sciences Ltd. had blended expired fluids in its vaccines and...
Read More
FILE - In this Nov. 23, 2015, file photo, the Pfizer logo is displayed at world headquarters in New York. Pfizer Inc. (PFE) on Tuesday, July 31, 2018, reported second-quarter earnings of $3.87 billion. (AP Photo/Mark Lennihan, File)
July 31, 2018 - 1:12 pm
Pfizer's top executives are predicting the Trump administration will try to eliminate big rebates off prescription drug prices that manufacturers pay to middlemen, a move that could sharply reduce patients' out-of-pocket costs. Pfizer shares jumped 3 percent on the comments, made to analysts during...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. on Friday, July 27 reported second-quarter profit of $1.71 billion. The Kenilworth, New Jersey-based company said it had profit of 63 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and restructuring costs, were $1.06 per share. (AP Photo/Seth Wenig, File)
July 27, 2018 - 10:34 am
Soaring sales of cancer drugs, vaccines and veterinary medicines drove Merck & Co.'s 5 percent jump in second-quarter revenue and the company lifted its outlook for the year. Long known for primary care with its allergy, cholesterol, diabetes, heart and osteoporosis medications and shots to...
Read More
FILE - This Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. Johnson & Johnson reports earnings Tuesday, July 17, 2018. (AP Photo/Matt Rourke, File)
July 17, 2018 - 8:28 am
Fueled by a 20 percent sales jump in its prescription drugs business, Johnson & Johnson posted a 3 percent increase in second-quarter profit. Still, the world's biggest maker of health care products trimmed its forecast for 2018. J&J's prescription medicine business, which had lagged its...
Read More
This 1975 microscope image made available by the Centers for Disease Control and Prevention shows a cluster of smallpox viruses. On Friday, July 13, 2018, U.S. regulators announced the approval of the first treatment for smallpox _ a deadly disease that was wiped out four decades ago _ in case the virus is used in a terror attack. (Fred Murphy/CDC via AP)
July 13, 2018 - 7:08 pm
U.S. regulators Friday approved the first treatment for smallpox — a deadly disease that was wiped out four decades ago — in case the virus is used in a terror attack. Smallpox, which is highly contagious, was eradicated worldwide by 1980 after a huge vaccination campaign. But people born since...
Read More
July 13, 2018 - 1:11 pm
OKLAHOMA CITY (AP) — The federal Centers for Medicare and Medicaid Services has approved Oklahoma's Medicaid program for a first-in-the-nation drug pricing experiment that supporters say could save taxpayer dollars and provide patients with the most effective medications for their ailments. Under...
Read More
FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The Food and Drug Administration is considering easing the process for drugmakers to get approval to sell some prescription medicines over the counter, a move to offer consumers convenience and lower prices. FDA Commissioner Dr. Scott Gottlieb said Tuesday, July 17, 2018 that the agency has developed tentative guidelines for drugmakers to do so, while maintaining safety standards. (AP Photo/Andrew Harnik, File)
July 12, 2018 - 5:53 pm
The U.S. Food and Drug Administration said Thursday it wants to more aggressively fight medication shortages that have led to rationing of some drugs and disrupted patient care. The agency announced plans for a task force to find ways to improve the supply of crucial drugs. It's a new approach for...
Read More
July 10, 2018 - 8:17 pm
WASHINGTON (AP) — President Donald Trump says pharmaceutical company Pfizer is "rolling back price hikes, so American patients don't pay more." Trump is tweeting that he and Health Secretary Alex Azar discussed the issue Tuesday with Pfizer CEO Ian Read. Pfizer has issued a statement saying Read...
Read More
June 07, 2018 - 10:29 am
BERLIN (AP) — German pharmaceutical company Bayer AG says it has completed its purchase of U.S. seed and weed-killer maker Monsanto Co. Bayer said Thursday that it is now the sole owner of the company and Monsanto shares will no longer trade on the New York Stock Exchange. Bayer has put the cost of...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 6:10 am
WASHINGTON (AP) — Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general'...
Read More

Pages